WebFeb 10, 2024 · Biophytis ADSs have been approved for listing on the Nasdaq Capital Market under the ticker symbol “BPTS” and are expected to begin trading on February 10, 2024 at 10 a.m., Eastern Time. WebFind the latest Biophytis S.A. (ALBPS.PA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Biophytis SA American Depositary Share (BPTS) Option Chain - Nasdaq
WebBiophytis (NASDAQ:BPTS) stock is seeing wild movement on Thursday morning but it’s nothing for traders to be worried about. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES … WebJan 12, 2024 · Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the … mks microvision 2
Biophytis Announces Receipt of Nasdaq Notice
WebBiophytis. Biophytis is a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratoy failure in patients suffering from COVID-19. WebJan 12, 2024 · Biophytis SA received a deficiency notice from The Nasdaq Stock Market, Inc. stating that the Company has not filed its financial information for the six-month period ended June 30, 2024 on a Form 6-K and as a result the Company no longer complies with Nasdaq's listing rules for continued listing set forth in the Listing Rule 5250. WebApr 10, 2024 · Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19, informs its … in heat wheels